| Item | Value |
|---|---|
| DrugBank ID | DB01609 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 112 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 2 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 3 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 4 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 5 | beta thalassemia | TxGNN Knowledge Graph |
| 6 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 7 | hemoglobinopathy | TxGNN Knowledge Graph |
| 8 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 9 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 10 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 11 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 12 | beta thalassemia | TxGNN Knowledge Graph |
| 13 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 14 | hemoglobinopathy | TxGNN Knowledge Graph |
| 15 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 16 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 17 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 18 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 19 | beta thalassemia | TxGNN Knowledge Graph |
| 20 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 21 | hemoglobinopathy | TxGNN Knowledge Graph |
| 22 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 23 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 24 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 25 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 26 | beta thalassemia | TxGNN Knowledge Graph |
| 27 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 28 | hemoglobinopathy | TxGNN Knowledge Graph |
| 29 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 30 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 31 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 32 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 33 | beta thalassemia | TxGNN Knowledge Graph |
| 34 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 35 | hemoglobinopathy | TxGNN Knowledge Graph |
| 36 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 37 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 38 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 39 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 40 | beta thalassemia | TxGNN Knowledge Graph |
| 41 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 42 | hemoglobinopathy | TxGNN Knowledge Graph |
| 43 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 44 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 45 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 46 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 47 | beta thalassemia | TxGNN Knowledge Graph |
| 48 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 49 | hemoglobinopathy | TxGNN Knowledge Graph |
| 50 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
(Showing top 50 of 112 predictions)
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.